EFFICACY AND SAFETY OF ANTIOXIDANT SUPPLEMENTATION IN WOMEN WITH ENDOMETRIOSIS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

In: International Journal of Innovative Technologies in Social Science · 2026 · vol. 1(4(52)) · doi:10.31435/ijitss.4(52).2026.6772 · W7233551375
OA: gold CC0

Abstract

Background: Endometriosis affects ~10% of reproductive-age women, causing pain and infertility. Limitations of conventional therapies have driven interest in targeting oxidative stress, though clinical evidence on antioxidant efficacy and safety remains inconsistent. Aim: To evaluate the efficacy, safety, and biomarker impact of antioxidant supplementation in women with endometriosis based on randomized controlled trials (RCTs). Materials and Methods: Following PRISMA guidelines, a systematic PubMed search identified 119 unique records, screened via Rayyan based on PICOS criteria. Eligible studies were RCTs evaluating antioxidant supplementation versus control in adult women with confirmed endometriosis. Ultimately, 26 RCTs met all inclusion criteria. Results: Selected antioxidants significantly attenuated oxidative and inflammatory markers (e.g., reduced hs-CRP with vitamin D; lower IL-1$\beta$, TNF-α, and MDA with astaxanthin/nanocurcumin; suppressed MMP-2/9 and VEGF with resveratrol). Clinically, vitamins C/E, nanocurcumin, selenium, and vitamin D reduced pelvic pain, whereas melatonin, fish oil, and resveratrol showed mixed or no benefit. Quality of life (EHP-30) did not improve vs. placebo, though adjunctive curcumin enhanced generic quality of life and sexual function. Astaxanthin and nanocurcumin increased mature oocyte yield and embryo quality during ART, but without significant improvements in clinical pregnancy rates. Conclusions: Antioxidants effectively modulate oxidative, inflammatory, and angiogenic pathways in endometriosis. However, biochemical improvements do not consistently translate into clinical benefits regarding pain, quality of life, or pregnancy rates. Due to high study heterogeneity and inconsistent safety data, antioxidants should be considered investigational adjunctive options rather than routine treatment.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Source provenance

openalex
last seen: 2026-11-17T06:02:21.439193+00:00
License: CC0 · commercial use OK